APEX 3D S Diamond Tibia
Paragon 28, Inc. · Decision date Oct 7, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K261120, the APEX 3D S Diamond Tibia from Paragon 28, Inc., on October 7, 2026, under 21 CFR 888.3110 with product code HSN and orthopedic specialty. This is a 510(k) clearance, not a PMA approval. The device is a tibial tray component of the APEX 3D Total Ankle Replacement, Short Stem Tibia System, described as a line extension adding a porous central stem—a tapered lattice around a solid core—while keeping the tray design, dimensions, materials and dovetail locking mechanism of the cleared APEX 3D Short Stem Tibia Tray.
The primary predicate is the APEX 3D Total Ankle Replacement (K240259), with the Zimmer Persona Personalized Knee System (K221479) listed as a reference device. The summary states clinical data were not necessary and that performance testing met predetermined acceptance criteria. The FDA database lists a receipt date of April 3, 2026, while the cover letter and summary give September 18, 2026; the discrepancy is unresolved in the source. Long-term clinical outcomes for the porous stem are not provided.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 7, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261120
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Paragon 28, Inc.
- Product code
- HSN
- Decision code
- SESE
- Decision date
- Oct 7, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Ankle, Semi-Constrained, Cemented, Metal/Polymer.
- Applicant
- Paragon 28, Inc.
- Product code
- HSN
- FDA device class
- 2
FDA decision timeline
K261120 received
Application receipt date recorded by FDA.
K261120 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Paragon 28, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Englewood, CO
Sources and methodology
- Original FDA record: K261120
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records